263 related articles for article (PubMed ID: 28099878)
1. Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology.
Zhang L; Xu MX; Yin QS; Zhu CY; Cheng XL; Ren YR; Zhuang PW; Zhang YJ
Toxicol Lett; 2017 Feb; 268():17-25. PubMed ID: 28099878
[TBL] [Abstract][Full Text] [Related]
2. Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.
Chaudhari U; Nemade H; Wagh V; Gaspar JA; Ellis JK; Srinivasan SP; Spitkovski D; Nguemo F; Louisse J; Bremer S; Hescheler J; Keun HC; Hengstler JG; Sachinidis A
Arch Toxicol; 2016 Nov; 90(11):2763-2777. PubMed ID: 26537877
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.
Holmgren G; Synnergren J; Bogestål Y; Améen C; Åkesson K; Holmgren S; Lindahl A; Sartipy P
Toxicology; 2015 Feb; 328():102-11. PubMed ID: 25529476
[TBL] [Abstract][Full Text] [Related]
4. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential genomic biomarkers for early detection of chemically induced cardiotoxicity in rats.
Mori Y; Kondo C; Tonomura Y; Torii M; Uehara T
Toxicology; 2010 Apr; 271(1-2):36-44. PubMed ID: 20211217
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.
Chaudhari U; Nemade H; Gaspar JA; Hescheler J; Hengstler JG; Sachinidis A
Arch Toxicol; 2016 Dec; 90(12):3087-3098. PubMed ID: 26842497
[TBL] [Abstract][Full Text] [Related]
7. miR-21-5p as a potential biomarker of inflammatory infiltration in the heart upon acute drug-induced cardiac injury in rats.
Gryshkova V; Fleming A; McGhan P; De Ron P; Fleurance R; Valentin JP; Nogueira da Costa A
Toxicol Lett; 2018 Apr; 286():31-38. PubMed ID: 29355689
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types.
Doherty KR; Talbert DR; Trusk PB; Moran DM; Shell SA; Bacus S
Toxicol Appl Pharmacol; 2015 May; 285(1):51-60. PubMed ID: 25841593
[TBL] [Abstract][Full Text] [Related]
9. Disruption of mitochondrial membrane potential coupled with alterations in cardiac biomarker expression as early cardiotoxic signatures in human ES cell-derived cardiac cells.
Jyoti S; Tandon S
Hum Exp Toxicol; 2019 Sep; 38(9):1111-1124. PubMed ID: 31179749
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
[TBL] [Abstract][Full Text] [Related]
11. Plasma miR-208 as a useful biomarker for drug-induced cardiotoxicity in rats.
Nishimura Y; Kondo C; Morikawa Y; Tonomura Y; Torii M; Yamate J; Uehara T
J Appl Toxicol; 2015 Feb; 35(2):173-80. PubMed ID: 25092230
[TBL] [Abstract][Full Text] [Related]
12. High Throughput Measurement of Ca++ Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A Cardiac Risk Assessment Characterization Using a Large Panel of Cardioactive and Inactive Compounds.
Lu HR; Whittaker R; Price JH; Vega R; Pfeiffer ER; Cerignoli F; Towart R; Gallacher DJ
Toxicol Sci; 2015 Dec; 148(2):503-16. PubMed ID: 26358003
[TBL] [Abstract][Full Text] [Related]
13. Genomic biomarkers for cardiotoxicity in rats as a sensitive tool in preclinical studies.
Nishimura Y; Morikawa Y; Kondo C; Tonomura Y; Fukushima R; Torii M; Uehara T
J Appl Toxicol; 2013 Oct; 33(10):1120-30. PubMed ID: 23558518
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
[TBL] [Abstract][Full Text] [Related]
15. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat model.
Todorova VK; Beggs ML; Delongchamp RR; Dhakal I; Makhoul I; Wei JY; Klimberg VS
PLoS One; 2012; 7(11):e48398. PubMed ID: 23209553
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
Himmel HM
J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
[TBL] [Abstract][Full Text] [Related]
18. Screening, verification, and optimization of biomarkers for early prediction of cardiotoxicity based on metabolomics.
Li Y; Ju L; Hou Z; Deng H; Zhang Z; Wang L; Yang Z; Yin J; Zhang Y
J Proteome Res; 2015 Jun; 14(6):2437-45. PubMed ID: 25919346
[TBL] [Abstract][Full Text] [Related]
19. Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells.
Andersson H; Steel D; Asp J; Dahlenborg K; Jonsson M; Jeppsson A; Lindahl A; Kågedal B; Sartipy P; Mandenius CF
J Biotechnol; 2010 Oct; 150(1):175-81. PubMed ID: 20633583
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity.
Holmgren G; Synnergren J; Andersson CX; Lindahl A; Sartipy P
Toxicol In Vitro; 2016 Aug; 34():26-34. PubMed ID: 27033315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
